Related references
Note: Only part of the references are listed.TNF-α drives human CD14+ monocytes to differentiate into CD70+ dendritic cells evoking Th1 and Th17 responses
Sanju Iwamoto et al.
JOURNAL OF IMMUNOLOGY (2007)
Requirement of tumor necrosis factor at and nuclear factor-kappa B in the induction by IFN-gamma of inducible nitric oxide synthase in macrophages
Virginia Vila-Del Sol et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Haplotype-specific gene expression profiles in a telomeric major histocompatibility complex gene cluster and susceptibility to autoimmune diseases
D. Mewar et al.
GENES AND IMMUNITY (2006)
Genetic polymorphism of the binding domain of surfactant protein-A2 increases susceptibility to meningococcal disease
Dominic L. Jack et al.
CLINICAL INFECTIOUS DISEASES (2006)
A tutorial on statistical methods for population association studies
David J. Balding
NATURE REVIEWS GENETICS (2006)
The natural history of meningococcal carriage and disease
C. L. Trotter et al.
EPIDEMIOLOGY AND INFECTION (2006)
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
T Bongartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
A functional promotor polymorphism of TNF-α is associated with primary gastric B-cell lymphoma
S Hellmig et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Nitric oxide detoxification systems enhance survival of Neisseria meningitidis in human macrophages and in nasopharyngeal mucosa
TM Stevanin et al.
INFECTION AND IMMUNITY (2005)
Additional genetic susceptibility for rheumatoid arthritis telomeric of the DRB1 locus
R Kilding et al.
ARTHRITIS AND RHEUMATISM (2004)
Is there a future for TNF promoter polymorphisms?
JP Bayley et al.
GENES AND IMMUNITY (2004)
Host genetic determinants of Neisseria meningitidis infections
M Emonts et al.
LANCET INFECTIOUS DISEASES (2003)
Activation of toll-like receptor 2 (TLR2) and TLR4/MD2 by Neisseria is independent of capsule and lipooligosaccharide (LOS) sialylation but varies widely among LOS from different strains
AC Pridmore et al.
INFECTION AND IMMUNITY (2003)
Variation within genes encoding interleukin-1 and the interleukin-1 receptor antagonist influence the severity of meningococcal disease
RC Read et al.
ANNALS OF INTERNAL MEDICINE (2003)
Nitric oxide metabolism in Neisseria meningitidis
MF Anjum et al.
JOURNAL OF BACTERIOLOGY (2002)
Infliximab-induced aseptic meningitis
H Marotte et al.
LANCET (2001)
A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via Toll-like receptor (TLR) 2 but not via TLR4/MD2
AC Pridmore et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Underestimation of meningococci in tonsillar tissue by nasopharyngeal swabbing
RJ Sim et al.
LANCET (2000)
An interleukin-1 genotype is associated with fatal outcome of meningococcal disease
RC Read et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
